Johnson & Johnson, United States
Disclosure information not submitted.
3C-02 - Economic Outcomes for VELYS Robotic-Assisted Solution (VRAS) and MAKO for Total Knee Arthroplasty
Monday, August 25, 20258:20 AM - 8:25 AM ET
3C-04 - Does the risk of readmission and revision events after cervical spine fusion differ in hospital billing versus claims data?
Monday, August 25, 20258:30 AM - 8:35 AM ET
